Trimming the fat with an IVIG approval process

Transfus Apher Sci. 2012 Jun;46(3):349-52. doi: 10.1016/j.transci.2012.03.030. Epub 2012 Apr 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Drug Approval*
  • Female
  • Humans
  • Immunoglobulins, Intravenous / administration & dosage*
  • Immunoglobulins, Intravenous / adverse effects
  • Male
  • Obesity*
  • Ontario
  • Practice Guidelines as Topic

Substances

  • Immunoglobulins, Intravenous